Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management

被引：0
|
作者：
Shlermine A. Everidge
Jia Sun
Mediget Teshome
Nina Tamirisa
Susie Sun
Taiwo Adesoye
Emily Nia
Therese Bevers
Isabelle Bedrosian
Miral Patel
Puneet Singh
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Breast Surgical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Biostatistics
[3] The University of Texas MD Anderson Cancer Center,Department of Breast Imaging
[4] The University of Texas MD Anderson Cancer Center,Department of Clinical Cancer Prevention
来源：
Annals of Surgical Oncology | 2024年 / 31卷
关键词：
ALH; LCIS; Lobular neoplasia; MRI; MRI-guided biopsy; Upgrade; Breast cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2224 / 2230
页数：6
相关论文
共 50 条
  • [1] Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management
    Everidge, Shlermine A.
    Sun, Jia
    Teshome, Mediget
    Tamirisa, Nina
    Sun, Susie
    Adesoye, Taiwo
    Nia, Emily
    Bevers, Therese
    Bedrosian, Isabelle
    Patel, Miral
    Singh, Puneet
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2224 - 2230
  • [2] Management of Lobular Neoplasia Diagnosed via MRI-guided Biopsy
    Everidge, Shlermine
    Sun, Jia
    Teshome, Mediget
    Tamirisa, Nina
    Sun, Susie
    Adesoye, Taiwo
    Kapoor, Megha
    Nia, Emily
    Bevers, Therese
    Bedrosian, Isabelle
    Patel, Miral
    Singh, Puneet
    ANNALS OF SURGICAL ONCOLOGY, 2023, 30 (SUPPL 2) : S434 - S435
  • [3] Lobular neoplasia occult on conventional imaging and diagnosed on MRI-guided biopsy: can we estimate upgrade on surgical pathology?
    Amitai, Yoav
    Menes, Tehillah S.
    Scaranelo, Anabel
    Fleming, Rachel
    Kulkarni, Supriya
    Ghai, Sandeep
    Cil, Tulin
    Done, Susan
    Freitas, Vivianne
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 184 (03) : 881 - 890
  • [4] Lobular neoplasia occult on conventional imaging and diagnosed on MRI-guided biopsy: can we estimate upgrade on surgical pathology?
    Yoav Amitai
    Tehillah S. Menes
    Anabel Scaranelo
    Rachel Fleming
    Supriya Kulkarni
    Sandeep Ghai
    Tulin Cil
    Susan Done
    Vivianne Freitas
    Breast Cancer Research and Treatment, 2020, 184 : 881 - 890
  • [5] Lobular neoplasia detected at MRI-guided biopsy: imaging findings and outcomes
    Chikarmane, Sona A.
    Harrison, Beth T.
    Giess, Catherine S.
    Pinkney, David M.
    Gombos, Eva C.
    CLINICAL IMAGING, 2021, 78 (78) : 171 - 178
  • [6] Predicting surgical upgrade of breast lesions detected by MRI-guided biopsy
    Chen, Angela
    Brem, Rachel
    CANCER RESEARCH, 2018, 78 (04)
  • [7] The Rate of Upgrade for Lobular Neoplasia in MRI-Guided Core Needle Biopsy: A Study of 63 Cases from Four Different Institutions
    Desouki, M. M.
    Karabakhtsian, R.
    Sanati, S.
    Li, Z.
    Reig, B.
    Kumar, P.
    Chen, X.
    Wang, D.
    Huang, X.
    Liu, S.
    Khoury, T.
    MODERN PATHOLOGY, 2014, 27 : 44A - 45A
  • [8] The Rate of Upgrade for Lobular Neoplasia in MRI-Guided Core Needle Biopsy: A Study of 63 Cases from Four Different Institutions
    Desouki, M. M.
    Karabakhtsian, R.
    Sanati, S.
    Li, Z.
    Reig, B.
    Kumar, P.
    Chen, X.
    Wang, D.
    Huang, X.
    Liu, S.
    Khoury, T.
    LABORATORY INVESTIGATION, 2014, 94 : 44A - 45A
  • [9] High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy
    Cha, Eumee
    Ambinder, Emily B.
    Oluyemi, Eniola T.
    Mullen, Lisa A.
    Panigrahi, Babita
    Rossi, Joanna
    Di Carlo, Philip A.
    Myers, Kelly S.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 196 (03) : 517 - 525
  • [10] High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy
    Eumee Cha
    Emily B. Ambinder
    Eniola T. Oluyemi
    Lisa A. Mullen
    Babita Panigrahi
    Joanna Rossi
    Philip A. Di Carlo
    Kelly S. Myers
    Breast Cancer Research and Treatment, 2022, 196 : 517 - 525
12345